天香丹颗粒对冠脉搭桥术后患者临床疗效的影响  

Clinic observation of Tianxiangdan in patients after coronary artery bypass grafting

作　　者：李静茹[1] 席耀明[2] 王晓峰[2] 安冬青[2] 

机构地区：[1]新疆医科大学研究生院,乌鲁木齐830000 [2]新疆医科大学附属中医医院,乌鲁木齐830000

出　　处：《中华中医药杂志》2011年第9期2129-2131,共3页China Journal of Traditional Chinese Medicine and Pharmacy

基　　金：新疆维吾尔自治区科技支疆项目(No.200991135)~~

摘　　要：目的:评价天香丹颗粒对冠脉搭桥术后患者临床疗效的影响。方法:60例冠脉搭桥术后患者依随机数字表分为治疗组(30例)和对照组(30例),对照组(30例)采用西医常规治疗,治疗组(30例)在西医治疗的基础上,采用天香丹颗粒治疗,1个月为1个疗程,共观察3个疗程。结果:3个月后到治疗终点,治疗组的中医总有效率为83.3%,对照组为63.3%,两组总有效率比较差异有统计学意义(P<0.05);两组左心室射血分数治疗前后比较差异有统计学意义(P<0.05),且治疗组的左心室射血分数提高程度优于对照组(P<0.05);两组6min步行试验治疗前后比较差异有统计学意义(P<0.05),且治疗组优于对照组(P<0.05)。结论:天香丹颗粒改善中医症状,促进术后患者的恢复,改善临床症状。Objective： To evaluate the clinic efficiency of Tianxiangdan on patients with coronary artery bypass grafting （CABG）. Methods： 60 Patients of CABG randomly divided into treatment group （n=30） and control group （n=30）. Control group were given regular treatment, while treatment group were given the Tianxiangdan Granula with regular treatment, one month as one course, and the study lasted for three courses. Results： After 3-month treatment, there were obvious deffrences in TCM syndrome of two groups （P〈0.05）. The total effective rate in the treatment group was 83.3% and in the control group was 63.3% （P〈0.05）; The function of heart before and after the test, two groups were effective （P〈0.05）, but there were statistical different between two groups （P〈0.05）; In terms of 6 min walking test was evidently effective rate in the treatment group than that in the control group （P〈0.05）. Conclusion： Tianxiangdan can improve the TCM symptoms and heart function of patients after coronary artery bypass grafting and accelerate the rehabilitation progess.

关 键 词：天香丹 冠脉搭桥术 临床疗效 

分 类 号：R259[医药卫生—中西医结合]